» Articles » PMID: 15223906

Effect of Venous Drainage Site on Insulin Action After Simultaneous Pancreas-kidney Transplantation

Overview
Journal Transplantation
Specialty General Surgery
Date 2004 Jun 30
PMID 15223906
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of the present study was to determine the influence of the venous drainage site on insulin homeostasis in simultaneous pancreas-kidney (SPK) transplant recipients.

Methods: The study included 12 SPK patients with portal venous drainage (P) and 11 SPK patients with systemic venous drainage (S) of pancreas allograft. All of the participants presented similar characteristics. The euglycemic hyperinsulinemic clamp was performed using a 0.4-mU/kg/min insulin infusion. An infusion of [6,6-(2)H2] glucose was used to determine glucose turnover at the basal state and during the clamp to determine liver and peripheral tissue sensitivity to insulin.

Results: Minor changes in glycemia and insulinemia were shown: fasting plasma glucose was significantly higher in the SPK-P group and insulinemia was higher in the SPK-S group. Hepatic glucose production was similar in both groups. During the clamp, insulin levels were higher in SPK-S recipients, but hepatic glucose production was suppressed in both groups. Glucose use was lower in SPK-S recipients than in SPK-P recipients, 3.32 +/-1.41 mg/kg/min and 4.70 +/-1.64 mg/kg/min, respectively (P<0.02). Basal and under-clamp free fatty acid levels were similar. In addition, no significant difference in cholesterol and low-density lipoprotein levels was shown, whereas high-density lipoprotein levels were higher in the SPK-S group; triglycerides during fasting and under clamp were significantly higher in the SPK-P group.

Conclusions: In both groups, neither hepatic nor peripheral insulin resistance was detected. In SPK-S recipients, the authors have showed only a lower insulin clearance and a slight decreased peripheral responsiveness to insulin without modifications of lipid status.

Citing Articles

First World Consensus Conference on pancreas transplantation: Part II - recommendations.

Boggi U, Vistoli F, Andres A, Arbogast H, Badet L, Baronti W Am J Transplant. 2021; 21 Suppl 3:17-59.

PMID: 34245223 PMC: 8518376. DOI: 10.1111/ajt.16750.


Diabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.

Lauria M, Ribeiro-Oliveira Jr A Clin Diabetes Endocrinol. 2017; 2:14.

PMID: 28702248 PMC: 5471933. DOI: 10.1186/s40842-016-0032-x.


Transplantation of the pancreas.

Boggi U, Vistoli F, Egidi F, Marchetti P, De Lio N, Perrone V Curr Diab Rep. 2012; 12(5):568-79.

PMID: 22828824 DOI: 10.1007/s11892-012-0293-4.


Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients.

Boggi U, Vistoli F, Amorese G, Giannarelli R, Coppelli A, Mariotti R Rev Diabet Stud. 2011; 8(2):259-67.

PMID: 22189549 PMC: 3280011. DOI: 10.1900/RDS.2011.8.259.


Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver.

Stadler M, Anderwald C, Pacini G, Zbyn S, Promintzer-Schifferl M, Mandl M Diabetes. 2009; 59(1):215-8.

PMID: 19833878 PMC: 2797924. DOI: 10.2337/db09-0354.